SL
BLFS icon

Salomon & Ludwin’s BioLife Solutions BLFS Stock Holding History

Salomon & Ludwin’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$800 Sell
41
-270
-87% -$5.97K ﹤0.01% 2019
2025
Q4 		$7.87K Sell
311
-44
-12% -$1.15K ﹤0.01% 1577
2025
Q3 		$9.44K Buy
+355
New +$8.42K ﹤0.01% 1348

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Salomon & Ludwin's BLFS Position: Q1 2026 in Review

Salomon & Ludwin reduced its BioLife Solutions (BLFS) stake by 87% in Q1 2026, selling an estimated $5.97K and leaving 41 shares worth $800. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Salomon & Ludwin first reported a position in BLFS in Q3 2025 and has held it in 3 quarters since. The position peaked at $9.44K in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Salomon & Ludwin held 41 shares of BioLife Solutions worth $800 as of Q1 2026.
  • Salomon & Ludwin sold 270 BioLife Solutions shares in Q1 2026, an estimated $5.97K.
  • BioLife Solutions made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #2019 holding.
  • Salomon & Ludwin first reported a position in BioLife Solutions in Q3 2025 and has held it in 3 quarters since.
  • Salomon & Ludwin's BioLife Solutions position peaked at $9.44K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.